Exosome Bone Graft Composition for Stable Vesicle Preservation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Exosomes are fragile vesicles that require a suitable environment to maintain their integrity for therapeutic use, and existing bone graft materials do not effectively preserve their structure and functionality.

Innovation Solution

A bone graft material comprising an exosome mixture with dimethyl sulfoxide, epsilon poly L-lysine, and natural or man-made bone materials, which stabilizes and maintains the integrity of exosomes, allowing them to function effectively in bone graft applications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If exosomes are used in therapeutic compositions, then bone regeneration is enhanced, but exosome integrity is difficult to maintain

Engineering Contradiction:
Improveexosome integrityVSAvoidenvironmental degradation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses dimethyl sulfoxide (DMSO) as an intermediary substance to protect exosomes from environmental degradation. DMSO acts as a stabilizing agent that mediates between the exosomes and the external environment, preventing harmful interactions while maintaining exosome integrity and therapeutic functionality.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a protective environment for exosomes by formulating them in a stable composition containing DMSO and epsilon poly L-lysine. This formulation creates an inert-like environment that shields the fragile exosomes from degradation factors, allowing them to maintain their structural integrity and biological activity during storage and application.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

2Reliability

If natural bone material is used for grafting, then bone growth framework is provided, but disease transmission risk exists

Engineering Contradiction:
Improvebone growth supportVSAvoiddisease transmission
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and isolates exosomes from donor cells, separating the beneficial regenerative components from the harmful elements that could transmit disease. By using only the exosomal fraction rather than whole bone or tissue, the invention removes pathogens while retaining the therapeutic bone-regenerating properties.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses exosomes as a form of biological copy or surrogate that carries the regenerative information and signaling molecules needed for bone growth without containing the actual bone tissue that could transmit disease. The exosomes replicate the beneficial effects of bone tissue through their molecular contents rather than through direct tissue contact.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The exosome mixture enhances bone regeneration by providing a stable environment for exosomes to fuse with living cells, promoting effective bone growth and healing in dental and orthopedic procedures.

Implementation Method 1

dimethyl sulfoxide; and epsilon poly L-lysine; and one or more natural bone materials, one or more man-made substitute bone materials or a combination thereof

Methodology Applied
Scientific EffectStabilization:

Implementation Method 2

dimethyl sulfoxide; and epsilon poly L-lysine; and one or more natural bone materials, one or more man-made substitute bone materials or a combination thereof

Methodology Applied
Scientific EffectPreservation: Preservative

Implementation Method 3

The exosome mixture enhances bone regeneration by providing a stable environment for exosomes to fuse with living cells, promoting effective bone growth and healing

Methodology Applied
Scientific EffectCell fusion:

Data Source

PatentUS20250352701A1Exosome bone graft systems, products and methods
Publication Date: 2025.11.20 GHALILI BABAK
  • US20250352701A1 patent drawing
  • US20250352701A1 patent drawing
  • US20250352701A1 patent drawing

AI summary

The present disclosure relates to exosome bone graft systems and compositions and preservative systems and compositions as well as methods of use and methods of manufacturing of them.